Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

The potential of heart transplantation from donation after circulatory death donors within the United Kingdom.

Messer S, Page A, Rushton S, Berman M, Tsui S, Catarino P, Large SR.

J Heart Lung Transplant. 2019 Aug;38(8):872-874. doi: 10.1016/j.healun.2019.04.007. Epub 2019 Apr 29. No abstract available.

PMID:
31353001
2.

A meta-analysis of the Miller Forensic Assessment of Symptoms Test (M-FAST).

Detullio D, Messer SC, Kennedy TD, Millen DH.

Psychol Assess. 2019 Jul 18. doi: 10.1037/pas0000753. [Epub ahead of print]

PMID:
31318253
3.

Paediatric donation after circulatory determined death heart transplantation using donor normothermic regional perfusion and ex situ heart perfusion: A case report.

Khushnood A, Butt TA, Jungschleger J, Henderson P, Smith JH, De Rita F, Nassar M, Page A, Messer S, Large S, Dark JH, Parry G, Reinhardt Z, Hasan A.

Pediatr Transplant. 2019 Jul 4:e13536. doi: 10.1111/petr.13536. [Epub ahead of print]

PMID:
31273913
4.

Heart Transplantation With Donation After Circulatory Death.

Niederberger P, Farine E, Raillard M, Dornbierer M, Freed DH, Large SR, Chew HC, MacDonald PS, Messer SJ, White CW, Carrel TP, Tevaearai Stahel HT, Longnus SL.

Circ Heart Fail. 2019 Apr;12(4):e005517. doi: 10.1161/CIRCHEARTFAILURE.118.005517.

PMID:
30998395
5.

In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival.

Watson CJE, Hunt F, Messer S, Currie I, Large S, Sutherland A, Crick K, Wigmore SJ, Fear C, Cornateanu S, Randle LV, Terrace JD, Upponi S, Taylor R, Allen E, Butler AJ, Oniscu GC.

Am J Transplant. 2019 Jun;19(6):1745-1758. doi: 10.1111/ajt.15241. Epub 2019 Feb 1.

PMID:
30589499
6.

Retrieval team-initiated early donor management increases the donor heart utilization rate for transplantation.

Barbero C, Ravaglioli A, Page AA, Betts GA, Fakelman SM, Pavlushkov E, Messer S, Parizkova B, Berman M, Tsui S.

Eur J Cardiothorac Surg. 2019 Mar 1;55(3):468-475. doi: 10.1093/ejcts/ezy293.

PMID:
30239643
7.

Lung donation after circulatory determined death: a single-centre experience.

Barbero C, Messer S, Ali A, Jenkins DP, Dunning J, Tsui S, Parmar J.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):309-315. doi: 10.1093/ejcts/ezy254.

PMID:
30084977
8.

Sex differences in affect-triggered lapses during smoking cessation: A daily diary study.

Messer S, Siegel A, Bertin L, Erblich J.

Addict Behav. 2018 Dec;87:82-85. doi: 10.1016/j.addbeh.2018.06.019. Epub 2018 Jun 18.

PMID:
29966963
9.

Human heart transplantation from donation after circulatory-determined death donors using normothermic regional perfusion and cold storage.

Messer S, Page A, Colah S, Axell R, Parizkova B, Tsui S, Large S.

J Heart Lung Transplant. 2018 Jul;37(7):865-869. doi: 10.1016/j.healun.2018.03.017. Epub 2018 Mar 30.

PMID:
29731238
10.

Heart transplantation from donation after circulatory determined death.

Page A, Messer S, Large SR.

Ann Cardiothorac Surg. 2018 Jan;7(1):75-81. doi: 10.21037/acs.2018.01.08. Review.

11.

Transplantation of Hearts Donated after Circulatory Death.

White CW, Messer SJ, Large SR, Conway J, Kim DH, Kutsogiannis DJ, Nagendran J, Freed DH.

Front Cardiovasc Med. 2018 Feb 13;5:8. doi: 10.3389/fcvm.2018.00008. eCollection 2018. Review.

12.

Outcome after heart transplantation from donation after circulatory-determined death donors.

Messer S, Page A, Axell R, Berman M, Hernández-Sánchez J, Colah S, Parizkova B, Valchanov K, Dunning J, Pavlushkov E, Balasubramanian SK, Parameshwar J, Omar YA, Goddard M, Pettit S, Lewis C, Kydd A, Jenkins D, Watson CJ, Sudarshan C, Catarino P, Findlay M, Ali A, Tsui S, Large SR.

J Heart Lung Transplant. 2017 Dec;36(12):1311-1318. doi: 10.1016/j.healun.2017.10.021. Epub 2017 Oct 24. Erratum in: J Heart Lung Transplant. 2018 Apr;37(4):535.

PMID:
29173394
13.

CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.

Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.

Int J Antimicrob Agents. 2017 Sep;50(3):352-358. doi: 10.1016/j.ijantimicag.2017.03.028. Epub 2017 Jul 6.

14.

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.

Pfaller MA, Messer SA, Rhomberg PR, Borroto-Esoda K, Castanheira M.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00161-17. doi: 10.1128/AAC.00161-17. Print 2017 Aug.

15.

Clinical and ethical challenges in heart transplantation from donation after circulatory determined death donors.

Large S, Tsui S, Messer S.

Curr Opin Organ Transplant. 2017 Jun;22(3):251-259. doi: 10.1097/MOT.0000000000000417. Review.

PMID:
28426448
16.

Ventriculo-arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease.

Axell RG, Messer SJ, White PA, McCabe C, Priest A, Statopoulou T, Drozdzynska M, Viscasillas J, Hinchy EC, Hampton-Till J, Alibhai HI, Morrell N, Pepke-Zaba J, Large SR, Hoole SP.

Physiol Rep. 2017 Apr;5(7). pii: e13227. doi: 10.14814/phy2.13227.

17.

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.

Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02045-16. doi: 10.1128/AAC.02045-16. Print 2017 Mar.

18.

Functional assessment and transplantation of the donor heart after circulatory death.

Messer SJ, Axell RG, Colah S, White PA, Ryan M, Page AA, Parizkova B, Valchanov K, White CW, Freed DH, Ashley E, Dunning J, Goddard M, Parameshwar J, Watson CJ, Krieg T, Ali A, Tsui S, Large SR.

J Heart Lung Transplant. 2016 Dec;35(12):1443-1452. doi: 10.1016/j.healun.2016.07.004. Epub 2016 Jul 16.

PMID:
27916176
19.

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.

Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M.

J Antimicrob Chemother. 2016 Oct;71(10):2868-73. doi: 10.1093/jac/dkw214. Epub 2016 Jun 10.

20.

Come and Knock on Our Door: Offenders' Perspectives on Home Visits Through Ecological Theory.

Patten R, La Rue E, Caudill JW, Thomas MO, Messer S.

Int J Offender Ther Comp Criminol. 2018 Feb;62(3):717-738. doi: 10.1177/0306624X16653741. Epub 2016 Jun 5.

PMID:
27272525
21.

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).

Castanheira M, Messer SA, Rhomberg PR, Pfaller MA.

Diagn Microbiol Infect Dis. 2016 Jun;85(2):200-4. doi: 10.1016/j.diagmicrobio.2016.02.009. Epub 2016 Feb 9.

PMID:
27061369
22.

Nylanderia deceptrix sp. n., a new species of obligately socially parasitic formicine ant (Hymenoptera, Formicidae).

Messer SJ, Cover SP, LaPolla JS.

Zookeys. 2016 Jan 13;(552):49-65. doi: 10.3897/zookeys.552.6475. eCollection 2016.

23.

Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation.

White CW, Lillico R, Sandha J, Hasanally D, Wang F, Ambrose E, Müller A, Rachid O, Li Y, Xiang B, Le H, Messer S, Ali A, Large SR, Lee TW, Dixon IM, Lakowski TM, Simons K, Arora RC, Tian G, Nagendran J, Hryshko LV, Freed DH.

Am J Transplant. 2016 Mar;16(3):783-93. doi: 10.1111/ajt.13543. Epub 2015 Dec 11.

24.

Resuscitating heart transplantation: the donation after circulatory determined death donor.

Messer S, Large S.

Eur J Cardiothorac Surg. 2016 Jan;49(1):1-4. doi: 10.1093/ejcts/ezv357. Epub 2015 Oct 20. Review. No abstract available.

PMID:
26487100
25.

How I Have Changed Over Time as a Psychotherapist.

Messer SB.

J Clin Psychol. 2015 Nov;71(11):1104-14. doi: 10.1002/jclp.22220. Epub 2015 Sep 11.

PMID:
26361285
26.
27.

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).

Pfaller MA, Messer SA, Jones RN, Castanheira M.

J Antibiot (Tokyo). 2015 Sep;68(9):556-61. doi: 10.1038/ja.2015.29. Epub 2015 Apr 22.

PMID:
25899126
28.

Virtual patients: development in cancer nursing education.

Moule P, Pollard K, Armoogum J, Messer S.

Nurse Educ Today. 2015 Jul;35(7):875-80. doi: 10.1016/j.nedt.2015.02.009. Epub 2015 Feb 21.

PMID:
25735908
29.
30.

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

Pfaller MA, Rhomberg PR, Messer SA, Castanheira M.

Diagn Microbiol Infect Dis. 2015 Apr;81(4):259-63. doi: 10.1016/j.diagmicrobio.2014.11.008. Epub 2014 Nov 25.

PMID:
25600842
31.

Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint.

Ren P, Luo M, Lin S, Ghannoum MA, Isham N, Diekema DJ, Pfaller MA, Messer S, Lockhart SR, Iqbal N, Chaturvedi V.

Antimicrob Agents Chemother. 2015 Mar;59(3):1759-66. doi: 10.1128/AAC.04545-14. Epub 2014 Dec 15.

32.

Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.

Castanheira M, Messer SA, Jones RN, Farrell DJ, Pfaller MA.

Int J Antimicrob Agents. 2014 Oct;44(4):320-6. doi: 10.1016/j.ijantimicag.2014.06.007. Epub 2014 Jul 23.

PMID:
25129315
33.

Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.

Castanheira M, Messer SA, Rhomberg PR, Dietrich RR, Jones RN, Pfaller MA.

Mycopathologia. 2014 Aug;178(1-2):1-9. doi: 10.1007/s11046-014-9772-2. Epub 2014 Jun 21.

PMID:
24952015
34.

Normothermic donor heart perfusion: current clinical experience and the future.

Messer S, Ardehali A, Tsui S.

Transpl Int. 2015 Jun;28(6):634-42. doi: 10.1111/tri.12361. Epub 2014 Jul 7. Review.

35.

"I Don't See Myself as Prison Material": Motivations for Entering a Rural Drug Court.

Patten R, Messer S, Candela K.

Int J Offender Ther Comp Criminol. 2015 Oct;59(11):1188-202. doi: 10.1177/0306624X14532321. Epub 2014 Apr 30.

PMID:
24788256
36.

Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.

Pfaller MA, Castanheira M, Messer SA, Rhomberg PR, Jones RN.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):198-204. doi: 10.1016/j.diagmicrobio.2014.03.004. Epub 2014 Mar 17.

PMID:
24736096
37.

Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.

Pfaller MA, Messer SA, Diekema DJ, Jones RN, Castanheira M.

J Clin Microbiol. 2014 Jan;52(1):108-14. doi: 10.1128/JCM.02481-13. Epub 2013 Oct 23.

38.

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.

Castanheira M, Woosley LN, Messer SA, Diekema DJ, Jones RN, Pfaller MA.

Antimicrob Agents Chemother. 2014;58(1):577-80. doi: 10.1128/AAC.01674-13. Epub 2013 Oct 14.

39.

Three mechanisms of change in psychodynamic therapy: insight, affect, and alliance.

Messer SB.

Psychotherapy (Chic). 2013 Sep;50(3):408-12. doi: 10.1037/a0032414.

PMID:
24000861
40.

In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.

Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M.

J Clin Microbiol. 2013 Aug;51(8):2608-16. doi: 10.1128/JCM.00863-13. Epub 2013 Jun 5.

42.

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA.

Clin Infect Dis. 2013 Jun;56(12):1724-32. doi: 10.1093/cid/cit136. Epub 2013 Mar 13. Erratum in: Clin Infect Dis. 2014 Mar;58(5):754.

43.

In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.

Pfaller MA, Messer SA, Motyl MR, Jones RN, Castanheira M.

Antimicrob Agents Chemother. 2013 Feb;57(2):1065-8. doi: 10.1128/AAC.01588-12. Epub 2012 Dec 10.

44.

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST).

Pfaller MA, Messer SA, Motyl MR, Jones RN, Castanheira M.

J Antimicrob Chemother. 2013 Apr;68(4):858-63. doi: 10.1093/jac/dks466. Epub 2012 Nov 28.

PMID:
23190764
45.

Histologic analysis of the right atrioventricular junction in the adult human heart.

Messer S, Moseley E, Marinescu M, Freeman C, Goddard M, Nair S.

J Heart Valve Dis. 2012 May;21(3):368-73.

PMID:
22808841
46.

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

Pfaller MA, Chaturvedi V, Diekema DJ, Ghannoum MA, Holliday NM, Killian SB, Knapp CC, Messer SA, Miskou A, Ramani R.

Diagn Microbiol Infect Dis. 2012 Aug;73(4):365-8. doi: 10.1016/j.diagmicrobio.2012.05.008. Epub 2012 Jun 20.

PMID:
22726528
47.

Therapeutic alliance building during the child psychiatric intake: does VTC make a difference?

Penska K, Michael R, Messer SC, Smith R, Black NB, Cozza S.

Mil Med. 2012 May;177(5):541-5.

PMID:
22645880
48.

Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme.

Pfaller MA, Woosley LN, Messer SA, Jones RN, Castanheira M.

Mycopathologia. 2012 Oct;174(4):259-71. doi: 10.1007/s11046-012-9551-x. Epub 2012 May 13.

PMID:
22580756
49.

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.

Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN.

J Clin Microbiol. 2012 Apr;50(4):1199-203. doi: 10.1128/JCM.06112-11. Epub 2012 Jan 25.

50.

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.

Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Jones RN.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):252-9. doi: 10.1016/j.diagmicrobio.2011.07.007. Epub 2011 Sep 13.

PMID:
21917395

Supplemental Content

Loading ...
Support Center